Navigation Links
Palatin Technologies, Inc. to Raise $2.0 Million Dollars in Registered Direct Offering
Date:6/25/2010

CRANBURY, N.J., June 25 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) announced today that it has entered into definitive agreements with certain accredited investors to sell in a registered direct offering 10.0 million units at a price of $0.20 per unit for gross proceeds of $2.0 million, before deducting placement agent fees and other offering expenses.  Each unit will consist of one share of common stock and a warrant exercisable upon issuance and expiring one year after issuance to purchase 0.14 of one share of common stock at an exercise price of $0.20 per share of common stock.

The units were offered and sold pursuant to a prospectus supplement dated June 24, 2010 and an accompanying prospectus dated November 27, 2007, pursuant to the Company's effective shelf registration statement previously filed with the Securities and Exchange Commission. The closing of the offering is subject to certain conditions, and is expected to occur on or about June 30, 2010.

Rodman & Renshaw, LLC, a wholly owned subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM), served as the Company's exclusive placement agent for the offering.  

Net proceeds from the financing will be used to support clinical studies with PL-3994, and for funding research and development and general corporate purposes.  Palatin is developing PL-3994, a peptide mimetic natriuretic peptid
'/>"/>

SOURCE Palatin Technologies, Inc.; Rodman & Renshaw Capital Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on February 16, 2010
2. Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate
3. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
4. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on September 8, 2009
5. Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year 2009 Results; Teleconference and Webcast to be held on September 8, 2009
6. Palatin Technologies to Present at the Rodman & Renshaw 11th Annual Global Investment Conference
7. Palatin Technologies, Inc. to Raise $3.1 Million in Registered Direct Offering
8. Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration
9. Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate
10. Palatin Technologies Listing Compliance Plan Accepted by NYSE Alternext US
11. Palatin Technologies to Report Fiscal Year 2009 Second Quarter Results; Conference Call and Webcast on February 17, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... ... its GHS Label Guide . To align chemical container labeling with OSHA’s ... includes explanations of label components, an example of an accurate label, and pictogram ...
(Date:7/29/2015)... 29, 2015  Therapath Neuropathology ( www.Therapath.com ), ... with VA and Military Medical centers both domestically ... (ENFD) and Sweat Gland Nerve Fiber Density (SGNFD) ... https://therapath.com/skin ). Demonstration of a ... on punch skin biopsy is a highly sensitive ...
(Date:7/29/2015)... 2015  Indivior PLC (LON: INDV) today announced that ... was accepted and received Priority Review by the U.S. ... opioid overdose. This naloxone nasal spray comes as a ... absorption into the nasal mucosa. 1 The device ... may be better equipped to help an opioid overdose ...
(Date:7/29/2015)... 29, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company, is pleased to announce that the final design ... been locked.  Prototypes for industrial and regulatory testing ... application for CE mark clearance to market the ... 2016. (Photo: http://photos.prnewswire.com/prnh/20150729/248373 )  ...
Breaking Biology Technology:Brady Announces a New GHS Label Guide 2Neuropathology services for VA and Military health systems 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5
... PALO ALTO, Calif., Sept. 19 Telik, Inc.,(Nasdaq: ... corporate,overview at the UBS Global Life Sciences Conference in ... p.m. Eastern time (9:30 a.m. Pacific,time). Telik,s presentation will ... the Telik website, http://www.telik.com, through October 3,2007. ...
... 19 NPS,Pharmaceuticals, Inc. (Nasdaq: NPSP ) ... Office of Orphan Products Development has granted,orphan drug ... for the treatment of hypoparathyroidism, a rare deficiency ... therapy. Hypoparathyroidism afflicts approximately 65,000 people in ...
... (Nasdaq: SGMO ) announced today that Edward Lanphier,Sangamo,s ... on,the progress of Sangamo,s ZFP Therapeutic development programs and ... (ET) on Wednesday,September 26, 2007 at the UBS 2007 ... will be webcast live and may be accessed via ...
Cached Biology Technology:PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism 2PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism 3Sangamo BioSciences to Present at the UBS Global Life Sciences Conference 2
(Date:7/20/2015)... 2015  Acuity Market Intelligence,s latest research "The ... Commerce and Privacy" forecasts that between 2014 and ... be downloaded to smart mobile devices by 2.2 ... is projected to generate more than $67.9 billion ... forecast period.    "Biometrics is at ...
(Date:7/13/2015)... 13, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND ... and secure method to make payments.  With this ... introduced with its groundbreaking voice-direct payment patent application, ...
(Date:7/9/2015)... DUBLIN , July 07, 2015 ... has announced the addition of the "Biometrics ... and Forecasts 2015-2020" report to their offering. ... a major contributor to this growth and the ... US$5.5 billion in revenue for companies involved in ...
Breaking Biology News(10 mins):Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... line all the cavities and free,surfaces of the body, ... in the body organs. The organized structure of normal ... cancer, according to a,study by University of Helsinki scientists. ... the Proceedings of the National Academy of Sciences,(PNAS). ...
... have designed a nanoscale system to observe and ... By combining microfabricated cantilevers and magnetic ... study showed that cells respond to outside forces ... and their environment. The study also revealed that ...
... discovered why a bacterial lung infection is so lethal ... authorities had thought, according to research published August 23 ... first time that a toxin released by bacteria causes ... pneumonia. It is the bleeding, the authors argue, not ...
Cached Biology News:Cells united against cancer 2Bioengineers at University of Pennsylvania devise nanoscale system to measure cellular forces 2Bleeding, not inflammation, is major cause of early lung infection death 2Bleeding, not inflammation, is major cause of early lung infection death 3
The VersArray hybridization chamber is used for manual (coverslip) hybridization of microarrays. The chamber accommodates 2 slides and is watertight to allow incubation of slides in a water bath. Dim...
... The Eclipse is a state-of-the-art separation ... Fractionation (AFFF) technique. The Eclipse integrates easily ... DAWN, miniDAWN Tristar, as well as the ... size and molar mass distributions of the ...
Monoclonal antibodies conjugated with rhodamine...
... Moticam 2300 camera (MC2300) attaches to virtually ... trinocular port. Included in the standard package, ... software offers quick and accurate image capture, ... for examination or documentation purposes. The MC2300s ...
Biology Products: